{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:38:30Z","timestamp":1790786310977,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04345-8","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T19:28:23Z","timestamp":1754335703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Kazuki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takekoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Yoshikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Shimohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"4345_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","volume":"34","author":"JP Pin","year":"1995","unstructured":"Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 1995;34:1\u201326.","journal-title":"Neuropharmacology"},{"issue":"3","key":"4345_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.10451","volume":"53","author":"M Coesmans","year":"2003","unstructured":"Coesmans M, Sillevis Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, et al. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol. 2003;53(3):325\u201336.","journal-title":"Ann Neurol"},{"key":"4345_CR3","doi-asserted-by":"publisher","first-page":"E3012\u201325","DOI":"10.1212\/WNL.0000000000010854","volume":"95","author":"M Spatola","year":"2020","unstructured":"Spatola M, Petit Pedrol M, Maudes E, Simabukuro M, Mu\u00f1iz-Castrillo S, Pinto AL, et al. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology. 2020;95:E3012\u201325.","journal-title":"Neurology"},{"key":"4345_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"PS Smitt","year":"2000","unstructured":"Smitt PS, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.","journal-title":"N Engl J Med"},{"key":"4345_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2018.04.001","volume":"319","author":"N Yoshikura","year":"2018","unstructured":"Yoshikura N, Kimura A, Fukata M, Fukata Y, Yokoi N, Harada N, et al. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies. J Neuroimmunol. 2018;319:63\u20137.","journal-title":"J Neuroimmunol"},{"key":"4345_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1159\/000526632","volume":"14","author":"K Sakashita","year":"2023","unstructured":"Sakashita K, Nishida K, Takenaka Y, Yokota I, Yamasaki H, Nishimoto K, et al. Favorable outcome with intravenous immunoglobulin therapy in late-onset anti-mGluR1 encephalitis: a case report and literature review. Case Rep Neurol. 2023;14:494\u2013500.","journal-title":"Case Rep Neurol"},{"key":"4345_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.","journal-title":"N Engl J Med"},{"key":"4345_CR8","doi-asserted-by":"publisher","first-page":"1333658","DOI":"10.3389\/fneur.2024.1333658","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen X, Chen Y, Di L, Liu N, Liu T, Cai Y, et al. Cerebellar encephalitis associated with anti-mGluR1 antibodies: a case report and comprehensive literature review. Front Neurol. 2024;15:1333658.","journal-title":"Front Neurol"},{"key":"4345_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","volume":"86","author":"AS Lopez-Chiriboga","year":"2016","unstructured":"Lopez-Chiriboga AS, Komorowski L, K\u00fcmpfel T, Probst C, Hinson SR, Pittock SJ, et al. Metabotropic glutamate receptor type 1 autoimmunity: clinical features and treatment outcomes. Neurology. 2016;86:1009\u201313.","journal-title":"Neurology"},{"key":"4345_CR10","doi-asserted-by":"publisher","first-page":"1142160","DOI":"10.3389\/fneur.2023.1142160","volume":"14","author":"O Khojah","year":"2023","unstructured":"Khojah O, Makkawi S, Alghamdi S. Anti-mGluR1 encephalitis: case illustration and systematic review. Front Neurol. 2023;14:1142160.","journal-title":"Front Neurol"},{"key":"4345_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92:757\u201368.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4345_CR12","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3389\/fimmu.2019.01990","volume":"10","author":"C Kaegi","year":"2019","unstructured":"Kaegi C, Wuest B, Schreiner J, Steiner UC, Vultaggio A, Matucci A, et al. Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders. Front Immunol. 2019;10:1990.","journal-title":"Front Immunol"},{"key":"4345_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12974-022-02622-8","volume":"19","author":"Y Du","year":"2022","unstructured":"Du Y, Zhao C, Liu J, Li C, Yan Q, Li L, et al. Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies. J Neuroinflamm. 2022;19:259.","journal-title":"J Neuroinflamm"},{"key":"4345_CR14","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.2217\/fon.14.146","volume":"10","author":"A Abulayha","year":"2014","unstructured":"Abulayha A, Bredan A, El Enshasy H, Daniels I. Rituximab: modes of action, remaining dispute and future perspective. Future Oncol. 2014;10:2481\u201392.","journal-title":"Future Oncol"},{"key":"4345_CR15","doi-asserted-by":"publisher","first-page":"175628641984741","DOI":"10.1177\/1756286419847418","volume":"12","author":"M Christ","year":"2019","unstructured":"Christ M, M\u00fcller T, Bien C, Hagen T, Naumann M, Bayas A. Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature. Ther Adv Neurol Disord. 2019;12:1756286419847418.","journal-title":"Ther Adv Neurol Disord"},{"key":"4345_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mdc3.12841","volume":"6","author":"H Chaumont","year":"2019","unstructured":"Chaumont H, Petit A, Mameri T, Schollhammer R, Honnorat J, Lannuzel A. Successful management of anti-mGluR1 encephalitis with immunosuppressive treatment: dengue virus as a trigger? Mov Disord Clin Pract. 2019;6:727\u20138.","journal-title":"Mov Disord Clin Pract"},{"key":"4345_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1212\/WNL.0000000000005338","volume":"90","author":"JL Pedroso","year":"2018","unstructured":"Pedroso JL, Dutra LA, Espay AJ, H\u00f6ftberger R, Barsottini OGP. Video neuroimages: head titubation in anti-mGluR1 autoantibody-associated cerebellitis. Neurology. 2018;90:746\u20137.","journal-title":"Neurology"},{"key":"4345_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","volume":"20","author":"DSW Lee","year":"2021","unstructured":"Lee DSW, Rojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat Rev Drug Discov. 2021;20:179\u201399.","journal-title":"Nat Rev Drug Discov"},{"key":"4345_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2169\/internalmedicine.0987-18","volume":"58","author":"H Kasahara","year":"2019","unstructured":"Kasahara H, Sato M, Nagamine S, Makioka K, Tanaka K, Ikeda Y. Temporal changes on 123I-iomazenil and cerebral blood flow single-photon emission computed tomography in a patient with anti-N-methyl-D-aspartate receptor encephalitis. Intern Med. 2019;58:1501\u20135.","journal-title":"Intern Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04345-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04345-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04345-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:16:08Z","timestamp":1757348168000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04345-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4345"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04345-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5635966\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}